Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Micha Nübling

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Transfusion|June 21, 2013
How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testingBenjamin Müller, C Micha Nübling, Julia Kress, et al.
Transfusion|July 26, 2016
Hepatitis E viral loads in plasma pools for fractionationSally A Baylis, Victor M Corman, Edgar Ong, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 28, 2020
Summary of the WHO hearing on the development of product-specific reference materials for coagulation factor VIII and factor IX productsMikhail V Ovanesov, Stella C Williams, C Micha Nübling, et al.
The Journal of Infectious Diseases|April 4, 2002
Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentratesMichael Chudy, Christiane Stahl-Hennig, Annemarie Berger, et al.
Transfusion|May 21, 2009
Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissionsC Micha Nübling, Margarethe Heiden, Michael Chudy, et al.
Transfusion|June 17, 2016
Viral nucleic acids in human plasma poolsWen Zhang, Linlin Li, Xutao Deng, et al.
Frontiers in Medicine|October 19, 2023
Regulation of blood-screening <i>in vitro</i> diagnostics in sub-Saharan African countries remains a challengeGoran Abdurrahman, Washington Samukange, Nyambe Lyoko, et al.
Transfusion|August 4, 2011
Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targetsMichael Chudy, Marijke Weber-Schehl, Lutz Pichl, et al.
Emerging Infectious Diseases|May 8, 2013
World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNASally A Baylis, Johannes Blümel, Saeko Mizusawa, et al.
Applied and Environmental Microbiology|June 14, 2015
World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNAC Micha Nübling, Sally A Baylis, Kay-Martin Hanschmann, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Transfusion|June 21, 2013
How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testingBenjamin Müller, C Micha Nübling, Julia Kress, et al.
Transfusion|July 26, 2016
Hepatitis E viral loads in plasma pools for fractionationSally A Baylis, Victor M Corman, Edgar Ong, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 28, 2020
Summary of the WHO hearing on the development of product-specific reference materials for coagulation factor VIII and factor IX productsMikhail V Ovanesov, Stella C Williams, C Micha Nübling, et al.
The Journal of Infectious Diseases|April 4, 2002
Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentratesMichael Chudy, Christiane Stahl-Hennig, Annemarie Berger, et al.
Transfusion|May 21, 2009
Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissionsC Micha Nübling, Margarethe Heiden, Michael Chudy, et al.
Transfusion|June 17, 2016
Viral nucleic acids in human plasma poolsWen Zhang, Linlin Li, Xutao Deng, et al.
Frontiers in Medicine|October 19, 2023
Regulation of blood-screening <i>in vitro</i> diagnostics in sub-Saharan African countries remains a challengeGoran Abdurrahman, Washington Samukange, Nyambe Lyoko, et al.
Transfusion|August 4, 2011
Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targetsMichael Chudy, Marijke Weber-Schehl, Lutz Pichl, et al.
Emerging Infectious Diseases|May 8, 2013
World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNASally A Baylis, Johannes Blümel, Saeko Mizusawa, et al.
Applied and Environmental Microbiology|June 14, 2015
World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNAC Micha Nübling, Sally A Baylis, Kay-Martin Hanschmann, et al.
Pageof 4